tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date

Overview of attention for article published in HIV/AIDS (Auckland, N.Z.), October 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 5 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 1 additional patents.